The resolution of the Expert Council on Interstitial Lung Diseases in Systemic Scleroderma (Moscow, October 14, 2019)
The conclusion of the Expert Council presents the results of discussing the diagnosis and therapy of interstitial lung diseases in systemic scleroderma. The reason for this discussion was the emergence of new data on the use of nintedanib in this category of patients.
Main Authors: | S. N. Avdeev, L. P. Ananyeva, E. V. Zhilyaev, E. V. Zonova, A. A. Klimenko, O. A. Koneva, A. M. Lila, E. S. Pershina, A. A. Stremoukhov, S. A. Terpigorev, I. E. Tyurin, N. A. Shostak |
---|---|
Format: | Article |
Language: | Russian |
Published: |
IMA-PRESS LLC
2020-03-01
|
Series: | Современная ревматология |
Online Access: | https://mrj.ima-press.net/mrj/article/view/1003 |
Similar Items
-
Interstitial lung disease in systemic sclerosis (systemic scleroderma)
by: L. P. Ananyeva, et al.
Published: (2021-03-01) -
RITUXIMAB TREATMENT FOR INTERSTITIAL LUNG INJURY IN SCLERODERMA SYSTEMATICA
by: Lidia Petrovna Ananieva, et al.
Published: (2013-12-01) -
Assessment of lung ultrasound in patients with scleroderma systematica and interstitial lung disease
by: Olga Borisovna Ovsyannikova, et al.
Published: (2013-06-01) -
Scleroderma as a paraneoplastic syndrome and tumors associated with scleroderma
by: N. A. Shostak, et al.
Published: (2020-05-01) -
Chronic Fibrosing Interstitial Lung Disease with Progressive Phenotype
by: L. P. Ananieva, et al.
Published: (2021-01-01)